STAT+: Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down
Negative
AI Analysis
Summary
Caribou Biosciences, co-founded by Jennifer Doudna, is shutting down after failing to secure funding needed for a late-stage clinical trial of its off-the-shelf CAR-T therapy for lymphoma.
Clinical Trial Data
Phase
late-stage
Outcome Details
Company shutting down due to inability to raise funding for late-stage clinical trial
Importance:8/10
Sentiment:
-1.00
company shutdownfunding failureCAR-T therapyoff-the-shelfclinical triallymphoma
Related Companies
Read the original article
Published by STAT News on October 7, 2026 8:30 AM